Holen Sie sich die Stockscreener-App
3.88
1.02%
-0.04
Schlusskurs vom Vortag:
$3.92
Offen:
$3.95
24-Stunden-Volumen:
534.97K
Relative Volume:
0.48
Marktkapitalisierung:
$288.01M
Einnahmen:
$6.96M
Nettoeinkommen (Verlust:
$-46.51M
KGV:
-22.61
EPS:
-0.1716
Netto-Cashflow:
$-37.99M
1W Leistung:
-10.80%
1M Leistung:
+3.19%
6M Leistung:
+1.84%
1J Leistung:
-69.13%
1-Tages-Spanne:
$3.82
$4.13
1-Wochen-Bereich:
$3.82
$4.335
52-Wochen-Spanne:
$1.60
$16.55
Perspective Therapeutics Inc Stock (CATX) Company Profile
Firmenname
Perspective Therapeutics Inc
Sektor
Branche
Telefon
509-375-1202
Adresse
350 Hills Street, Suite 106, Richland
Vergleichen Sie CATX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CATX
Perspective Therapeutics Inc
|
3.88 | 290.98M | 6.96M | -46.51M | -37.99M | -0.1716 |
|
ABT
Abbott Laboratories
|
128.55 | 222.72B | 43.11B | 13.98B | 6.66B | 7.98 |
|
BSX
Boston Scientific Corp
|
106.76 | 157.52B | 18.49B | 2.51B | 2.72B | 1.68 |
|
SYK
Stryker Corp
|
400.41 | 153.08B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
91.64 | 118.44B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
81.16 | 47.20B | 5.69B | 4.15B | 623.10M | 6.95 |
Perspective Therapeutics Inc Stock (CATX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-03-13 | Eingeleitet | H.C. Wainwright | Buy |
| 2025-03-07 | Eingeleitet | Scotiabank | Sector Outperform |
| 2024-11-25 | Herabstufung | BofA Securities | Buy → Neutral |
| 2024-10-24 | Eingeleitet | UBS | Buy |
| 2024-10-01 | Eingeleitet | Wedbush | Outperform |
| 2024-09-25 | Eingeleitet | Truist | Buy |
| 2024-07-25 | Eingeleitet | BofA Securities | Buy |
| 2024-05-09 | Eingeleitet | Cantor Fitzgerald | Overweight |
Alle ansehen
Perspective Therapeutics Inc Aktie (CATX) Neueste Nachrichten
Perspective Therapeutics Inc. Earnings Report Breakdown: What Investors Should KnowAI Driven Buy Alert Trade Blueprint Released - metal.it
Applying chart zones and confluence areas to Perspective Therapeutics Inc.Investment Timing Strategy with Market Filters - Newser
Volume spikes in Perspective Therapeutics Inc. stock – what they meanSector Rotation Outlook With Historical Summary - Newser
How to read the order book for Perspective Therapeutics Inc.Daily Market Movers Screener with Filters - Newser
What makes Perspective Therapeutics Inc. stock price move sharplyEntry Confirmation Using Short-Term Forecasting - Newser
Is Perspective Therapeutics Inc. the Top Chart Pick This WeekCommunity Strategy With High Win Rate Backtested - metal.it
How volatile is Perspective Therapeutics Inc. stock compared to the marketFinancial News Outlook For 2025 - jammulinksnews.com
Is it the right time to buy Perspective Therapeutics Inc. stockAI Powered Target Finder For Consistent Profits - jammulinksnews.com
When is Perspective Therapeutics Inc. stock expected to show significant growthDaily Trading Opportunities For Consistent Profits - jammulinksnews.com
Why is Perspective Therapeutics Inc. stock attracting strong analyst attentionAchieve breakthrough investment performance - jammulinksnews.com
Volume spikes in Perspective Therapeutics Inc. stock – what they mean Asset Growth Pattern and Return Summary - Newser
What are the latest earnings results for Perspective Therapeutics Inc.Achieve breakthrough gains with expert advice - jammulinksnews.com
What is the risk reward ratio of investing in Perspective Therapeutics Inc. stockInvest with confidence backed by data - jammulinksnews.com
How many analysts rate Perspective Therapeutics Inc. as a “Buy”Invest smarter and grow your wealth faster - jammulinksnews.com
Perspective Therapeutics Inc. Company’s Quarterly Earnings Growth: What the Numbers SayFree Predictions - Newser
Moving Average Trends for Perspective Therapeutics Inc. Stock: What They IndicateSmart High Yield Swing Trades - Newser
How Perspective Therapeutics Inc. stock performs during market volatilityFree Real-Time Trading Opportunities - Newser
What analysts say about Perspective Therapeutics Inc. stockTriple returns potential - PrintWeekIndia
What drives Perspective Therapeutics Inc. stock priceBreakthrough financial growth - PrintWeekIndia
Is Perspective Therapeutics Inc. a good long term investmentFree Buy/Sell Signal Notifications - Autocar Professional
Should I buy Perspective Therapeutics Inc. stock before earningsOutstanding capital returns - jammulinksnews.com
What institutions are buying Perspective Therapeutics Inc. stock nowConsistent high-yield stocks - jammulinksnews.com
Perspective Therapeutics Inc. Stock Analysis and ForecastFree Consultation - Autocar Professional
Will Perspective Therapeutics Inc. stock benefit from interest rate changesHigh-yield trading alerts - jammulinksnews.com
Perspective Therapeutics to present updated data on cancer therapy at ESMO - Investing.com Canada
Perspective Therapeutics to present updated data on cancer therapy at ESMO By Investing.com - Investing.com South Africa
Perspective Therapeutics Announces Acceptance of VMT-?-NET Data for Presentation at the ESMO Congress 2025 | CATX Stock News - GuruFocus
Perspective Therapeutics, Inc. Announces Acceptance of Updated Data for [212Pb]VMT-α-NET Program at ESMO Congress 2025 - Nasdaq
Perspective Therapeutics Announces Acceptance of VMT-α-NET Data for Presentation at the ESMO Congress 2025 - The Globe and Mail
Major Breakthrough: Phase 2 NET Cancer Treatment Shows Mature Safety Data in 44 Patients, ESMO Preview - Stock Titan
High‑Growth Oncology Market Projected For US$900bn in Revenue Despite Policy Headwinds - MarketScreener
High‑Growth Oncology Market Projected For US$900bn in Revenue Despite Policy Headwinds - Benzinga
Finanzdaten der Perspective Therapeutics Inc-Aktie (CATX)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.33%
4.32%
Kapitalisierung:
|
Volumen (24h):